176 related articles for article (PubMed ID: 22064990)
1. Substratum compliance regulates human trabecular meshwork cell behaviors and response to latrunculin B.
Wood JA; McKee CT; Thomasy SM; Fischer ME; Shah NM; Murphy CJ; Russell P
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9298-303. PubMed ID: 22064990
[TBL] [Abstract][Full Text] [Related]
2. Substratum stiffness and latrunculin B modulate the gene expression of the mechanotransducers YAP and TAZ in human trabecular meshwork cells.
Thomasy SM; Morgan JT; Wood JA; Murphy CJ; Russell P
Exp Eye Res; 2013 Aug; 113():66-73. PubMed ID: 23727052
[TBL] [Abstract][Full Text] [Related]
3. Substratum stiffness and latrunculin B regulate matrix gene and protein expression in human trabecular meshwork cells.
Thomasy SM; Wood JA; Kass PH; Murphy CJ; Russell P
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):952-8. PubMed ID: 22247475
[TBL] [Abstract][Full Text] [Related]
4. The effect of biophysical attributes of the ocular trabecular meshwork associated with glaucoma on the cell response to therapeutic agents.
McKee CT; Wood JA; Shah NM; Fischer ME; Reilly CM; Murphy CJ; Russell P
Biomaterials; 2011 Mar; 32(9):2417-23. PubMed ID: 21220171
[TBL] [Abstract][Full Text] [Related]
5. Low dose latrunculin-A inhibits dexamethasone-induced changes in the actin cytoskeleton and alters extracellular matrix protein expression in cultured human trabecular meshwork cells.
Liu X; Wu Z; Sheibani N; Brandt CR; Polansky JR; Kaufman PL
Exp Eye Res; 2003 Aug; 77(2):181-8. PubMed ID: 12873448
[TBL] [Abstract][Full Text] [Related]
6. The formation of cortical actin arrays in human trabecular meshwork cells in response to cytoskeletal disruption.
Murphy KC; Morgan JT; Wood JA; Sadeli A; Murphy CJ; Russell P
Exp Cell Res; 2014 Oct; 328(1):164-171. PubMed ID: 24992043
[TBL] [Abstract][Full Text] [Related]
7. Latrunculin B and substratum stiffness regulate corneal fibroblast to myofibroblast transformation.
Thomasy SM; Raghunathan VK; Miyagi H; Evashenk AT; Sermeno JC; Tripp GK; Morgan JT; Murphy CJ
Exp Eye Res; 2018 May; 170():101-107. PubMed ID: 29421383
[TBL] [Abstract][Full Text] [Related]
8. Effect of latrunculin-A on morphology and actin-associated adhesions of cultured human trabecular meshwork cells.
Cai S; Liu X; Glasser A; Volberg T; Filla M; Geiger B; Polansky JR; Kaufman PL
Mol Vis; 2000 Jul; 6():132-43. PubMed ID: 10930474
[TBL] [Abstract][Full Text] [Related]
9. Effect of latrunculin-B on outflow facility in monkeys.
Peterson JA; Tian B; Geiger B; Kaufman PL
Exp Eye Res; 2000 Mar; 70(3):307-13. PubMed ID: 10712817
[TBL] [Abstract][Full Text] [Related]
10. Latrunculin B effects on trabecular meshwork and corneal endothelial morphology in monkeys.
Sabanay I; Tian B; Gabelt BT; Geiger B; Kaufman PL
Exp Eye Res; 2006 Feb; 82(2):236-46. PubMed ID: 16054137
[TBL] [Abstract][Full Text] [Related]
11. Latrunculin-A increases outflow facility in the monkey.
Peterson JA; Tian B; Bershadsky AD; Volberg T; Gangnon RE; Spector I; Geiger B; Kaufman PL
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):931-41. PubMed ID: 10102290
[TBL] [Abstract][Full Text] [Related]
12. Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes.
Ethier CR; Read AT; Chan DW
Invest Ophthalmol Vis Sci; 2006 May; 47(5):1991-8. PubMed ID: 16639007
[TBL] [Abstract][Full Text] [Related]
13. Influence of actin cytoskeletal integrity on matrix metalloproteinase-2 activation in cultured human trabecular meshwork cells.
Sanka K; Maddala R; Epstein DL; Rao PV
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2105-14. PubMed ID: 17460268
[TBL] [Abstract][Full Text] [Related]
14. Latrunculins' effects on intraocular pressure, aqueous humor flow, and corneal endothelium.
Peterson JA; Tian B; McLaren JW; Hubbard WC; Geiger B; Kaufman PL
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1749-58. PubMed ID: 10845595
[TBL] [Abstract][Full Text] [Related]
15. Acto-myosin drug effects and aqueous outflow function.
Epstein DL; Rowlette LL; Roberts BC
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):74-81. PubMed ID: 9888429
[TBL] [Abstract][Full Text] [Related]
16. A tissue-engineered human trabecular meshwork hydrogel for advanced glaucoma disease modeling.
Li H; Bagué T; Kirschner A; Strat AN; Roberts H; Weisenthal RW; Patteson AE; Annabi N; Stamer WD; Ganapathy PS; Herberg S
Exp Eye Res; 2021 Apr; 205():108472. PubMed ID: 33516765
[TBL] [Abstract][Full Text] [Related]
17. Cytoskeletal drugs prevent posterior capsular opacification in human lens capsule in vitro.
Sureshkumar J; Haripriya A; Muthukkaruppan V; Kaufman PL; Tian B
Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):507-14. PubMed ID: 22138731
[TBL] [Abstract][Full Text] [Related]
18. TGFβ2 Regulates Human Trabecular Meshwork Cell Contractility
Li H; Henty-Ridilla JL; Bernstein AM; Ganapathy PS; Herberg S
Curr Eye Res; 2022 Aug; 47(8):1165-1178. PubMed ID: 35481448
[TBL] [Abstract][Full Text] [Related]
19. Effects of MISA A on actin cytoskeleton of cultured HTM cells and intraocular pressure of rats and glaucomatous monkeys.
Wang H; Liu X; Guo L; Gabelt BT; Lee PY; Podos SM; Wang N; Kaufman PL
Curr Eye Res; 2007 Oct; 32(10):843-50. PubMed ID: 17963104
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of latrunculin-A on dexamethasone-induced fibronectin production in cultured human trabecular meshwork cells.
Wang Y; Tan J; Zhuo YH; Wang CL; Liu XY; Cai SP
Int J Ophthalmol; 2011; 4(3):239-42. PubMed ID: 22553652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
